The prevalence and incidence of medical conditions in healthy pharmaceutical company employees who volunteer to participate in medical research

British Journal of Clinical Pharmacology

Volumn 48, Issue 1, 1999, Pages 25-31

  Singh, S D ^a   Williams, A J ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Healthy; Incidence; Medical conditions; Prevalence; Screening; Volunteer

Indexed keywords

ALCOHOL;

ALCOHOL CONSUMPTION; ANAMNESIS; ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; EMPLOYEE; HUMAN; HYPERLIPIDEMIA; INCIDENCE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; MEDICAL RESEARCH; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; THYROID DISEASE; VOLUNTEER;

ADULT; DRUG INDUSTRY; EPIDEMIOLOGY; HEALTH STATUS; HUMANS; INCIDENCE; OCCUPATIONS; PREVALENCE; RETROSPECTIVE STUDIES; VOLUNTARY WORKERS;

EID: 0033058180     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00961.x     Document Type: Article

References (29)

1. 1 Orme M, Harry J, Routledge P, Hobson S. Healthy Volunteer Studies in Great Britain: the results of a survey into 12 months activity in this field. Br J Clin Pharmacol 1989; 27: 125-133.
2. 2 Darragh A, Kenny M, Lambe R, Brick I. Sudden death of a volunteer. Lancet 1985; i: 93-94.
3. 3 Death of a volunteer (Editorial). Br Med J 1985; 290: 1369-1370.
4. 4 Watson, N, Wild, PJ. The importance of general practitioner information in selection of volunteers for clinical trials. Br J Clin Pharmacol 1992; 33: 197-199.
5. 5 Coggon D, Rose G, Barker DJP. Epidemiology for the uninitiated, 3rd edn. BMJ publications 1993.
6. 6 Stinson JC, Pears JS, Williams AJ, Campbell RWF. Use of 24 h ambulatory ECG recordings in the assessment of new chemical entities in healthy volunteers. Br J Clin Pharmacol 1995; 39: 651-656.
7. 7 Adamson H, Jacobs A, Warrington S. Reference ranges for laboratory safety tests in young healthy subjects. Int J Pharmaceut Med 1998; 12: 293-298.
8. 8 Beacham L. No. safe limits to alcohol consumption warns BMA. Br Med J 1995; 310: 1142.
9. 9 Sever P, Beevers G, Bulpitt C, et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. Br Med J 1993; 306: 983-987.
10. 10 Collins R, Peto R, McMahon S, et al. Blood pressure and coronary heart disease. Lancet 1990; 335: 827-838.
11. 11 Durrington PN, ed. Hyperlipidaemia Diagnosis and Management, 2nd edn. London, Butterworth Heinemann 1994.
12. 12 Manninen V, Huttunen JK, Tenkanen L, et al. High density lipoprotein cholesterol as a risk factor for coronary heart disease in The Helsinki Heart Study. In High density lipoproteins and atherosclerosis 2, ed Miller NE, Amsterdam, Excerpta Medica 1989.
13. 13 Danese MD, Pawl NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination, a decision and cost effective analysis. J Am Med Ass 1996; 276: 285-292.
14. 14 Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community, the Whickam survey. Clin Endocronol 1977; 7: 483-493.
15. 15 Weetman AP. Hypothyroidism: screening and subclinical disease. Br Med J 1997; 314: 1175-1178.
16. 16 Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community, a 20 year follow up of the Whickham survey. Clin Endocrinol 1995; 43: 55-68.
17. 17 Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine, 10th edn. Blackwell Science, 1997: 5-6.
18. 18 Kaltwasser JP. International forum. Vox Song 1981; 41: 336-343.
19. 19 Josephson M. Pre-excitation syndromes. In Clinical Cardiac Electrophysiology, Lea and Febiger, 1993: 311-416.
20. 20 Camm AJ, Katritsas D. The diagnosis of tachyarrythmias. In Diseases of the Heart eds Julian DG, Camm AJ, Fox KM, Hall RJC, Pool Wilson PA. W.B. Saunders, 1996: 578-606.
21. 21 Kline GJ, Gulamhusein FS. Intermittent pre-excitation in the Wolf Parkinson White syndrome. Am J Cardiol 1983; 52: 292-296.
22. 22 Munger TM, Packer DL, Hammil SC, et al. A Population Study of the Natural History of Wolf Parkinson White Syndrome in Olmsted County Minnesota 1953-1989. Circulation 1993; 87: 866-873.
23. 23 Brooks R, Garan H, Smith PN, Rosein JN. Cardiac surgery in the prevention of sudden death. In The Prevention of Sudden Cardiac Death, eds Kostis JB, Sanders, M. Wiley Liss, 1990: 221-261.
24. 24 Gersh BJ, Opie LH. Which drug for which disease. In Drugs for the Heart ed Opie LH. W.B. Saunders, 1995: 308-345.
25. 25 Van Lieshout JJ, Wiling W, Karemaker JM, Eckberg DL. The vasovagal response. Clin Sci 1991; 1981: 575-586.
26. 26 Waddel S. Vasovagal syncopy. Crit Care Nurse 1989; 9: 35-43.
27. 27 Munoz CD, Montoya FA, Valbuena MP, Vazques GJG, Cara MY, Berrio LA. Factors associated with vasovagal reactions during blood donation. Biol Clin Hematol 1993; 15: 41-45.
28. 28 Tizes R. Cardiac arrest during routine venepuncture. J Am Med Ass 1976; 236: 1846-1847.
29. 29 Rossoff MH, Cohen MV. Profound bradycardia after amyl nitrate in patients with a tendency to vasovagal episodes. Br Heart J 1986; 55: 97-100.